159 related articles for article (PubMed ID: 19590186)
1. Mechanisms and influence of octreotide-induced regulation of somatostatin receptor 2 on hepatocellular carcinoma.
Hua YP; Yin XY; Peng BG; Li SQ; Lai JM; Liang HZ; Liang LJ
Chemotherapy; 2009; 55(5):312-20. PubMed ID: 19590186
[TBL] [Abstract][Full Text] [Related]
2. Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.
Liu HL; Huo L; Wang L
Acta Pharmacol Sin; 2004 Oct; 25(10):1380-6. PubMed ID: 15456543
[TBL] [Abstract][Full Text] [Related]
3. [Effects of octreotide on necrosis of hepatocellular carcinoma xenografts in nude mice].
Chen S; Xie Y; Wang CH; Tang CW
Ai Zheng; 2009 Jul; 28(7):673-8. PubMed ID: 19624890
[TBL] [Abstract][Full Text] [Related]
4. [The study of inhibition effect of octreotide on the growth of hepatocellular carcinoma xenografts in situ in nude mice].
Hua YP; Huang JF; Liang LJ; Li SQ; Lai JM; Liang HZ
Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(11):721-5. PubMed ID: 16008961
[TBL] [Abstract][Full Text] [Related]
5. Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
Jia WD; Xu GL; Xu RN; Sun HC; Wang L; Yu JH; Wang J; Li JS; Zhai ZM; Xue Q
J Cancer Res Clin Oncol; 2003 Jun; 129(6):327-34. PubMed ID: 12811549
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinoma cells express somatostatin receptor subtype 2 and respond to octreotide treatment.
Zhao B; Zhao H; Zhao N; Zhu XG
J Hepatobiliary Pancreat Surg; 2002; 9(4):497-502. PubMed ID: 12483273
[TBL] [Abstract][Full Text] [Related]
7. Treatment of liver cancer in mice by the intratumoral injection of an octreotide-based temperature‑sensitive gel.
Zhang L; Yu S; Duan Z; Wang Q; Tian G; Tian Y; Zhao W; Wang H; Zhang C; Guo S; Liu Q; He G; Bian T; Chang J; Jin X; Cui D
Int J Mol Med; 2014 Jan; 33(1):117-27. PubMed ID: 24173662
[TBL] [Abstract][Full Text] [Related]
8. [Effect of HBV X gene transfection on octreotide-inhibited growth of hepatocellular carcinoma cell line HepG2].
Xie Y; Tang CW; Wang CH
Ai Zheng; 2005 Aug; 24(8):965-9. PubMed ID: 16086874
[TBL] [Abstract][Full Text] [Related]
9. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
Notas G; Kolios G; Mastrodimou N; Kampa M; Vasilaki A; Xidakis C; Castanas E; Thermos K; Kouroumalis E
J Hepatol; 2004 May; 40(5):792-8. PubMed ID: 15094227
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition effects of octreotide on the growth of hepatocellular carcinoma in vitro and in vivo].
Wang C; Tang C; Tang L
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1194-7. PubMed ID: 11769709
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice.
Li Y; Si JM; Zhang J; Du J; Wang F; Jia B
World J Gastroenterol; 2005 Jul; 11(25):3953-7. PubMed ID: 15991301
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin analog inhibits the growth of insulinoma cells by p27-mediated G1 cell cycle arrest.
Aoki T; Motoi F; Sakata N; Naitoh T; Katayose Y; Egawa S; Miyazaki J; Unno M
Pancreas; 2014 Jul; 43(5):720-9. PubMed ID: 24694834
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1/Smad2/3 signaling pathway modulates octreotide antisecretory and antiproliferative effects in pituitary somatotroph tumor cells.
Picech F; Sosa LD; Perez PA; Cecenarro L; Oms SR; Coca HA; De Battista JC; Gutiérrez S; Mukdsi JH; Torres AI; Petiti JP
J Cell Physiol; 2021 Oct; 236(10):6974-6987. PubMed ID: 33682941
[TBL] [Abstract][Full Text] [Related]
14. Targeted paclitaxel-octreotide conjugates inhibited the growth of paclitaxel-resistant human non-small cell lung cancer A549 cells in vitro.
Liu Y; Xia H; Wang Y; Han W; Qin J; Gao W; Qu X; Wang X
Thorac Cancer; 2021 Nov; 12(22):3053-3061. PubMed ID: 34617400
[TBL] [Abstract][Full Text] [Related]
15. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of somatostatin receptor expression in human hepatocellular carcinoma tissue to serum alpha-fetoprotein concentration].
Xie YM; Yan LN; Wei B; Guo MM; Tang CW
Ai Zheng; 2007 Jul; 26(7):688-92. PubMed ID: 17626741
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR.
Taboada GF; Luque RM; Neto LV; Machado Ede O; Sbaffi BC; Domingues RC; Marcondes JB; Chimelli LM; Fontes R; Niemeyer P; de Carvalho DP; Kineman RD; Gadelha MR
Eur J Endocrinol; 2008 Mar; 158(3):295-303. PubMed ID: 18299461
[TBL] [Abstract][Full Text] [Related]
18. [Tumor growth inhibition of paclitaxel-octreotide conjugates on human non small cell lung cancer: experiment with mice].
Shen HC; Wang XW; Liu YG
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2498-503. PubMed ID: 19080633
[TBL] [Abstract][Full Text] [Related]
19. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma.
Reynaert H; Rombouts K; Vandermonde A; Urbain D; Kumar U; Bioulac-Sage P; Pinzani M; Rosenbaum J; Geerts A
Gut; 2004 Aug; 53(8):1180-9. PubMed ID: 15247189
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of somatostatin receptor type 2 (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment.
Froidevaux S; Hintermann E; Török M; Mäcke HR; Beglinger C; Eberle AN
Cancer Res; 1999 Aug; 59(15):3652-7. PubMed ID: 10446977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
